Skip to main content
. 2020 Jan 21;12:463–473. doi: 10.2147/CMAR.S229083

Figure 3.

Figure 3

LINC00963 knockdown in OC represses cells to proliferate in vivo and in vitro. (A, B) CCK-8 and EdU assays examine the proliferation of OC cells receiving treatment with si-LINC00963 or si-NC. (C) QRT-PCR measurement of LINC00963 expression in LINC00963 stable knockdown SKOV3 cells. (D) Heterotopic xenograft image. (E) Tumor volume in LINC00963 knockdown and control groups is tested every 3 days, and tumor weight is detected subsequent to the resection of the tumor through surgery. **p<0.01, ***p<0.001.